Morgan Stanley Adjusts Palo Alto Networks Price Target Amid Shifting Demand Trends Over a Third of TwoYear SIPs Across MarketCap Categories Show Losses Data Reveals Gilead Sciences Acquires Tubulis in 315 Billion Deal to Strengthen Oncology Pipeline SEC Proposes Allowing Public Companies to Opt Out of Quarterly Earnings Reports Starbucks Discontinues AI Inventory Management Program Across North America Wingstop Shares Slide 12 as Profit Misses Market Estimates Cirrus Logic Q1 2026 Earnings EPS Beats Estimates by 86 Shares Edge Lower CMRC Q1 2026 Earnings EPS Surges Past Estimates Yet Stock Declines ePlus inc PLUS Q1 2026 Earnings EPS Surges 4075 Above Estimates Stock Rises EYPT Q1 2026 Earnings EPS Misses Estimates as Clinicalstage Biotech Advances Pipeline ADPT Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Surprise SOLV Energy MWH Rallies Above Key Support Approaching Resistance Zone C4 Therapeutics CCCC Gains 114 as Stock Tests Key Resistance Near 374 Masonglory Limited MSGY Slides 149 Toward Key Support as Bearish Momentum Continues PLAYSTUDIOS MYPS Rebounds Sharply Testing Key Resistance After 6 Gain CENTA Q1 2026 Earnings EPS Surpasses Estimates by 154 Amid Modest Stock Uptick SLSN Q1 2026 Earnings Narrowed Loss Amidst Operational Uncertainty XENE Q1 2026 Earnings Narrowed Loss Beats Estimates as Pipeline Progress Continues Dole Q1 2026 Earnings EPS Misses Estimates Revenue Not Disclosed TRINZ Q1 2026 Earnings Modest EPS Beat Amid Stable Revenue Outlook LQDA Q1 2026 Earnings EPS Surges Past Estimates on 2431 Surprise Stock Rises 321 Fed Dissenters Explain Opposition to Signal of Rate Cut Bias BSAC Q1 2026 Earnings Earnings Beat Estimates as Net Income Rises Stock Slightly Down Eshallgo Inc EHGO Surges 17 as Buying Momentum Returns Antalpha Platform Holding ANTA Holds Steady at 802 as Market Awaits Catalyst TAT Technologies TATT Edges Lower as Resistance Holds at 3892 Strategic Education Inc STRA Slips 1 as Stock Tests Near Support Levels WEX Inc WEX Edges Higher A Closer Look at the Modest Uptick and Key Technical Levels ArriVent BioPharma AVBP Eases 168 Support at 261 in Focus After Sector Headwinds ECARX Holdings Warrants ECXWW Remain Flat at 005 Amid Low Volume